Here are relevant reports on : precision-oncology-market
-
Sugar Substitutes Market by Type (HFCS, High-intensity Sweeteners, Low-Intensity Sweeteners), Manufacturing Technology (Precision Fermentation, Enzymatic Conversion, Chemical Synthesis), Application, Form, Source, Region - Global Forecast to 2029
The sugar substitutes market is projected to reach USD 29.90 billion by 2029, at a CAGR of 4.9% during the forecast period. The report profiles key players such as Cargill, Incorporated (US), ADM (US), Ingredion (US), International Flavors & Fragrances Inc (US), Tate & Lyle (UK), Ajinomoto Co. Inc (Japan), GLG Life Tech Corp (Canada), Celanese Corporation (US), Roquette Frères (France), PCIPL (India), Mane SA. (France), Döhler GmbH (Germany), Morita Kagaku Kogyo Co., Ltd (Japan), zuChem (US), and Van Wankum Ingredients (Netherlands).
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
Seed Technologies Market/ SAT Market by Function (Seed Protection, Seed Enhancement, and Precision Seeding), Technology, Crop Type (Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables), and Region - Global Forecast to 2030
The seed technologies market is projected to expand from USD 9.35 billion in 2025 to USD 14.50 billion by 2030, at a CAGR of 9.2% during the forecast period. The report profiles key players such as BASF SE (Germany), Bayer AG (Germany), UPL (India), Corteva (US), Croda (UK), FMC (US), Nufarm (Australia), Syngenta (US), Germains Seed (UK), and Sumitomo Chemicals (Japan).
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Wireless Sensors Market in Precision Agriculture and Environmental Monitoring- Global Forecast and Analysis by Sensor Types, Applications and Geography (2011-2016)
Central to “ambient intelligence”; insights into the wireless sensors market for precision agriculture and environmental monitoring are detailed in this report. This report refers to environmental and agricultural monitoring as areas deployed with intelligent sensor interface that tracks, informs about, provides granular control of, and monitors the environment and agriculture in situ- real time.
- Published: July 2012
- Price: $ 4950
- TOC Available:
-
Precision Nutrition Market by Technology (Metabolomics, Genomics, Transcriptomics, Proteomics), Application (Disease Management, General Health & Wellness, Weight Management), Service Type, End-Use, Supplement, and Region - Global Forecast to 2029
The market for precision nutrition is projected to reach USD 12.89 billion by 2029, at a CAGR of 16.2% during the forecast period. The report profiles key players such as Viome Life Sciences, Inc. (US), Prenetics Global Limited (China), ZOE Limited (UK), myDNA Life Australia Pty Ltd. (Australia) , 23andMe, Inc. (US), DayTwo Inc (US), Nutrigenomix (Canada), Genesis Healthcare Co. (Japan), AMILI (Singapore), and SelfDecode (US).
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Sustainable Agriculture Market by Type (Organic Farming, Agroecology, Regenerative Agriculture, Conservation Agriculture, and Precision Agriculture), Application (Food Production, Bioenergy, Environmental Services, and Water Management), and Region - Global Forecast to 2029
The global market for sustainable agriculture, estimated to be US$ XX.X billion by 2024, has an impressive growth forecast, with growth expected to reach $XXX.X billion by 2029 at a compound annual growth rate (CAGR) of 6.1%. that is, within the forecast period. The key players in this market include Organic Valley (US), Nature's Path Foods (US), Eden Foods, Inc. (US), Deere & Company (US), Trimble Inc. (US), AGCO Corporation (US), AgJunction LLC (US), Raven Industries, Inc. (US), AG Leader Technology (US), Teejet Technologies (US), Topcon (US), Taranis (Israel), and others
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
US Electrosurgery Market by Product [Instruments (Bipolar, Monopolar), Accessories, Generators, Smoke Evacuation Systems], Surgery (Orthopedic, Cosmetic, Oncology, Urology, Neurology), End User (Hospitals, Ambulatory Surgical Centers) - Forecast to 2031
The US electrosurgery market, valued at USD 2.80 billion in 2025, stood at USD 2.94 billion in 2026 and is projected to advance at a resilient CAGR of 7.0% from 2026 to 2031, culminating in a forecasted valuation of USD 4.13 billion by the end of the period. The US electrosurgery market is experiencing strong growth, mainly driven by the increasing preference for minimally invasive surgery across various specialties, which requires the use of precise electrosurgical instruments.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT/FMT), Application (Oncology, Cardiology, Brain, Ophthalmology), End User (Hospitals, Diagnostic Centers, Academia, Research) & Region - Global Forecast to 2028
The global multimodal imaging market, valued at US$3.9 billion in 2022, stood at US$4.2 billion in 2023 and is projected to advance at a resilient CAGR of 5.7% from 2023 to 2028, culminating in a forecasted valuation of US$5.5 billion by the end of the period.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
North America Epigenetics Market by Product & Service [Enzymes, Kits & Reagents (Antibodies), Software], Method [DNA Methylation, Histone Modification], Technique [NGS, PCR], Application [Oncology, Immunology, Developmental Biology]-Forecast to 2030
The North America epigenetics market, valued at USD 0.84 billion in 2024, stood at USD 0.93 billion in 2025 and is projected to advance at a resilient CAGR of 13.8% from 2025 to 2030, culminating in a forecasted valuation of USD 1.78 billion by the end of the period. Growth of the North America epigenetics market is driven by a strong, well-funded life sciences ecosystem, with rising oncology and precision-medicine programs that rely on methylation and chromatin profiling.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Clinical Trial Services Market by Type (Lab, Monitoring, Contracts, Recruitment, PV, Biostatistics), Phase (I, II, III), Therapy (Oncology, Neurology, Dermatology, CVD), Modality (Biologics, Devices), Delivery Model (FSP, Hybrid) - Global forecast to 2031
The global clinical trial services market is projected to reach USD 97.41 billion by 2031, growing at a CAGR of 8.0% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.
- Published: April 2013
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
